PMID: 42195239

Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.

Abenavoli Ludovico, Loricchio Anna Giulia, Lopez Ivo, Morano Domenico, Ismaiel Abdulrahman, Dumitrascu Dan Lucian, Luzza Francesco

Medicina (Kaunas, Lithuania) · 2026

Vol. 62, Issue 5

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansIncretinsDisease ProgressionGlucagon-Like Peptide-1 Receptor AgonistsFatty LiverMetabolic SyndromeDiabetes Mellitus, Type 2Tirzepatide

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.